At the American Association of Laboratory Animal Science national meeting the Research Director of NeuroDigm Co. presented the theory and analgesic response of a new biogenic animal model of chronic pain More
The Collaboration will utilize the unique capabilities of Hybrigenics' PIM technology® to identify new targets for novel anti cancer drugs, during a 3 year- research program More